Africa: Path and MMV Launch 5-Year Global Initiative to Support Elimination of Relapsing Malaria

[PR Newswire] Geneva and Seattle -PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and effective radical cure to prevent relapse. VivAccess's work is funded by the Bill& Melinda Gates Foundation.
Source: AllAfrica News: Malaria - Category: Infectious Diseases Source Type: news